First Time Loading...

LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 3.03 USD -2.26% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

LVTX Price Targets Summary
LAVA Therapeutics NV

Wall Street analysts forecast LVTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LVTX is 6.94 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

LVTX Lowest Forecast
Wall Street Target
5.05 USD
67% Upside
LVTX Average Forecast
Wall Street Target
6.94 USD
129% Upside
LVTX Highest Forecast
Wall Street Target
11.55 USD
281% Upside
Lowest
Price Target
5.05 USD
67% Upside
Average
Price Target
6.94 USD
129% Upside
Highest
Price Target
11.55 USD
281% Upside

LVTX Last Price Targets
LAVA Therapeutics NV

The latest public price target was made on Mar 20, 2024 by Roger Song from Jefferies , who expects LVTX stock to rise by 98% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Roger Song
Jefferies
6 USD
Upside 98%
1 month ago
Mar 20, 2024
Jefferies Reiterates Buy Rating on Lava Therapeutics NV (LVTX) Following Earnings, 'LAVA 1266 tracking to 2Q24 IND submission'
StreetInsider
Roger Song
Jefferies
Price Target 6 USD
Upside/Downside 98%
View Source
LAVA Therapeutics NV Competitors:
Price Targets
ONCO
Oncopeptides AB
107% Upside
BIO
Biotest AG
19% Downside
A
298380
ABL Bio Inc
44% Upside
OCC
Orthocell Ltd
42% Upside
ONCO
Oncopeptides AB
107% Upside
BIO
Biotest AG
19% Downside
A
298380
ABL Bio Inc
44% Upside
OCC
Orthocell Ltd
42% Upside
NTRA
Natera Inc
9% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
TGTX
TG Therapeutics Inc
92% Upside
PTCT
PTC Therapeutics Inc
13% Downside

Revenue
Forecast

Revenue Estimate
LAVA Therapeutics NV

For the last 3 years the compound annual growth rate for LAVA Therapeutics NV's revenue is 25%.

25%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
LAVA Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

See Also

Summary
LVTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
LVTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LVTX stock valuation using valuation multiples.
Wall Street Estimates
LVTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LVTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LVTX's stock price target?
Price Target
6.94 USD

According to Wall Street analysts, the average 1-year price target for LVTX is 6.94 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.